Literature DB >> 17331039

Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa.

Mia Coetzer1, Tonie Cilliers, Maria Papathanasopoulos, Gita Ramjee, Salim Abdool Karim, Carolyn Williamson, Lynn Morris.   

Abstract

The envelope genes of 23 subtype C viral isolates from five individuals with early HIV-1 infection, followed for 2-4 years, were sequenced, analyzed, and correlated to coreceptor usage. Isolates from three participants used the CCR5 coreceptor at all time points, with no significant adaptations in the variable loop lengths, predicted N-linked glycosylation sites, or predicted change in sensitivity to monoclonal antibodies with disease progression. However, two individuals, Du151 and Du179, who had previously been shown to be dually infected with two phylogenetically distinct subtype C strains, were able to use CXCR4 with disease progression. The intraperson genetic diversity was 9% for Du151 and 3% for Du179 compared to <2% for participants who did not undergo a coreceptor switch. In both cases this coreceptor switch was associated with specific amino acid changes in the crown, an increased net amino acid charge in the V3 loop, and an increase in the length of the V1 region.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331039     DOI: 10.1089/aid.2006.0207

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  16 in total

1.  Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.

Authors:  Mia Coetzer; Rebecca Nedellec; Tonie Cilliers; Tammy Meyers; Lynn Morris; Donald E Mosier
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

2.  Short Communication: A Recombinant Variant with Increased Envelope Entry Efficiency Emerged During Early Infection of an HIV-1 Subtype C Dual Infected Rapid Progressor.

Authors:  Kerry Gordon; Shatha Omar; Andile Nofemela; Gama Bandawe; Carolyn Williamson; Zenda Woodman
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-20       Impact factor: 2.205

3.  Unusual five amino acid insert within subtype C HIV-1 envelope contributes to dual-tropism (X4R5).

Authors:  Elizabeth Johnston White; Bryan McColgan; Seble Kassaye; Lynn Zijenah; David Katzenstein
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

4.  Trends in HIV Prevalence in Pregnant Women in Rural South Africa.

Authors:  Ayesha B M Kharsany; Janet A Frohlich; Nonhlanhla Yende-Zuma; Gethwana Mahlase; Natasha Samsunder; Rachael C Dellar; May Zuma-Mkhonza; Salim S Abdool Karim; Quarraisha Abdool Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

5.  Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.

Authors:  Kabamba B Alexandre; Penny L Moore; Molati Nonyane; Elin S Gray; Nthabeleng Ranchobe; Ereck Chakauya; James B McMahon; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2013-08-15       Impact factor: 3.616

6.  Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.

Authors:  Kabamba Bankoledi Alexandre; Elin S Gray; Ralph Pantophlet; Penny L Moore; James B McMahon; Ereck Chakauya; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

7.  Evolution of CCR5 use before and during coreceptor switching.

Authors:  Mia Coetzer; Rebecca Nedellec; Janelle Salkowitz; Sherry McLaughlin; Yi Liu; Laura Heath; James I Mullins; Donald E Mosier
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression.

Authors:  Derseree Archary; Michelle L Gordon; Taryn N Green; Hoosen M Coovadia; Philip J R Goulder; Thumbi Ndung'u
Journal:  Retrovirology       Date:  2010-11-04       Impact factor: 4.602

9.  Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates.

Authors:  Ashika Singh; Taryn Page; Penny L Moore; Rachel L Allgaier; Keshni Hiramen; Hoosen M Coovadia; Bruce D Walker; Lynn Morris; Thumbi Ndung'u
Journal:  Virology       Date:  2009-08-19       Impact factor: 3.616

10.  SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

Authors:  Robert Sealy; Xiaoyan Zhan; Timothy D Lockey; Louis Martin; James Blanchard; Vicki Traina-Dorge; Julia L Hurwitz
Journal:  Curr HIV Res       Date:  2009-09       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.